Compare AU

Compare DRUG vs. IJH

Compare shares and ETFs on the ASX that you can trade on Pearler.

BetaShares Global Healthcare Currency Hedged ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare Currency Hedged ETF (DRUG) and the iShares S&P Mid-Cap ETF (IJH). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

DRUG

IJH

Popularity

Low

Low

Pearlers invested

62

36

Median incremental investment

$920.50

$1,043.50

Median investment frequency

Monthly

Monthly

Median total investment

$1,903.23

$3,574.33

Average age group

26 - 35

> 35


Key Summary

DRUG

IJH

Strategy

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

IJH.AX was created on 2000-05-22 by iShares. The fund's investment portfolio concentrates primarily on mid cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of midcapitalisation US equities.

Top 3 holdings

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

USD CASH (0.03 %)

AUD CASH (0.01 %)

Top 3 industries

Other (75.65 %)

Communication Services (33.53 %)

Health Care (24.25 %)

Other (99.67 %)

Communication Services (0.00 %)

Top 3 countries

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

United States (98.41 %)

United Kingdom of Great Britain and Northern Ireland (0.60 %)

Canada (0.54 %)

Management fee

0.57 %

0.07 %


Key Summary

DRUG

IJH

Issuer

BetaShares

iShares

Tracking index

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

S&P MidCap 400 Index - AUD

Asset class

ETF

ETF

Management fee

0.57 %

0.07 %

Price

$8.00

$52.04

Size

$183.750 million

$474.634 million

10Y return

N/A

191.23 %

Annual distribution yield (5Y)

1.89 %

7.60 %

Market

ASX

ASX

First listed date

08/08/2016

10/10/2007

Purchase fee

$6.50

$6.50


Community Stats

DRUG

IJH

Popularity

Low

Low

Pearlers invested

62

36

Median incremental investment

$920.50

$1,043.50

Median investment frequency

Monthly

Monthly

Median total investment

$1,903.23

$3,574.33

Average age group

26 - 35

> 35


Pros and Cons

DRUG

IJH

Pros

  • Higher exposure to US market

  • Lower management fee

  • Higher price growth

  • Higher distribution yield

Cons

  • Lower exposure to US market

  • Higher management fee

  • Lower price growth

  • Lower distribution yield

DRUG

IJH

Lower exposure to US market

Higher exposure to US market

Higher management fee

Lower management fee

Lower price growth

Higher price growth

Lower distribution yield

Higher distribution yield

Home